van Balen Peter, van Luxemburg-Heijs Simone A P, van de Meent Marian, van Bergen Cornelis A M, Halkes Constantijn J M, Jedema Inge, Falkenburg J H Frederik
Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
Transplantation. 2017 Dec;101(12):2850-2854. doi: 10.1097/TP.0000000000001713.
Donors for allogeneic stem cell transplantation are preferentially matched with patients for HLA-A, -B, -C, and -DRB1. Mismatches between donor and patient in these alleles are associated with an increased risk of graft-versus-host disease (GVHD). In contrast, HLA-DRB3, 4 and 5, HLA-DQ and HLA-DP are usually assumed to be low expression loci with limited relevance, although mismatches in HLA-DQ and HLA-DP can result in alloimmune responses. Mismatches in HLA-DRB3, 4, and 5 are usually not taken into account in donor selection.
Conversion of chimerism in the presence of GVHD after CD4 donor lymphocyte infusion was observed in a patient, HLA 10/10 matched, but mismatched for HLA-DRB3 and HLA-DPB1 compared with the donor. Alloreactive CD4 T cells were isolated from peripheral blood after CD4 donor lymphocyte infusion and recognition of donor-derived target cells transduced with the mismatched patient variant HLA-DRB3 and HLA-DPB1 molecule was tested.
A dominant polyclonal CD4 T cell response against patient's mismatched HLA-DRB3 molecule was found in addition to an immune response against patient's mismatched HLA-DPB1 molecule. CD4 T cells specific for these HLA class II molecules recognized both hematopoietic target cells as well as GVHD target cells.
In contrast to the assumption that mismatches in HLA-DRB3, 4, and 5 are not of immunogenic significance after HLA 10/10 matched allogeneic stem cell transplantation, we show that in this matched setting not only mismatches in HLA-DPB1, but also mismatches in HLA-DRB3 may induce a polyclonal allo-immune response associated with conversion of chimerism and severe GVHD.
异基因干细胞移植的供体优先与患者进行人类白细胞抗原A(HLA-A)、B、C和DRB1配型。这些等位基因中供体与患者的不匹配与移植物抗宿主病(GVHD)风险增加相关。相比之下,HLA-DRB3、4和5、HLA-DQ和HLA-DP通常被认为是低表达基因座,相关性有限,尽管HLA-DQ和HLA-DP的不匹配可导致同种免疫反应。在供体选择中通常不考虑HLA-DRB3、4和5的不匹配。
在一名患者中观察到,在输注CD4供体淋巴细胞后,存在GVHD的情况下嵌合体发生了转换。该患者HLA 10/10配型,但与供体相比,HLA-DRB3和HLA-DPB1不匹配。在输注CD4供体淋巴细胞后,从外周血中分离出同种反应性CD4 T细胞,并测试其对用不匹配的患者变异HLA-DRB3和HLA-DPB1分子转导的供体来源靶细胞的识别能力。
除了针对患者不匹配的HLA-DPB1分子的免疫反应外,还发现了针对患者不匹配的HLA-DRB3分子的显性多克隆CD4 T细胞反应。针对这些HLA II类分子的CD4 T细胞识别造血靶细胞以及GVHD靶细胞。
与HLA 10/10配型的异基因干细胞移植后HLA-DRB3、4和5的不匹配无免疫原性意义这一假设相反,我们发现,在这种配型情况下,不仅HLA-DPB1的不匹配,而且HLA-DRB3的不匹配都可能诱导与嵌合体转换和严重GVHD相关的多克隆同种免疫反应。